Basement membrane genes can predict the prognosis of patients with clear cell renal cell carcinoma (ccRCC) and are correlated with immune status

Author:

Hou Junhui1,Lv Zongwei1,Wang Yuan1,Wang Xia1,Chen Xiaonan1,Wang Kefeng1

Affiliation:

1. Shengjing Hospital of China Medical University

Abstract

Abstract Background: Basement membrane (BM) genes are an important factor in the process of clear cell renal cell carcinoma (ccRCC). Thus, identifying BMs with prognostic values in ccRCC is critical. Methods: The samples from TCGA were separated randomly into 2 cohorts, the training cohort, and the validation cohort. For the training cohort univariate Cox, Lasso, and multivariate Cox regression analyses were applied to identify prognostic BM genes and then construct a prognostic BM-genes’ signature. The nomogram was applied to predict prognosis at different clinicopathological stages and risk scores. GO and KEGG analyses were applied to the differentially expressed genes. Moreover, the CIBERSORT and ESTIMATE scores were calculated and compared between the high-risk cohort and the low-risk cohort. Results: A prognostic risk model of four BM genes, including ADAMTS14, COL7A1, HSPG2, and TIMP3, was constructed. There were also significant differences in survival time between the high-risk and low-risk groups for the validation cohort and the entire cohort. The risk model was validated as a new independent prognostic factor for ccRCC by univariate and multivariate Cox regression together with clinicopathological characteristics. In addition, a nomogram showed good prediction. The model can also analyze the possibility of immune escape and response to immunotherapy in ccRCC patients. In addition, the results of a pan-cancer analysis showed that these four model genes were associated with immune-related genes in a variety of cancers. Conclusion: The signature of four BM genes had a significant prognostic value for ccRCC. They may be promising targets for therapy, especially immune therapy.

Publisher

Research Square Platform LLC

Reference36 articles.

1. Renal cell carcinoma: a review of biology and pathophysiology;Nabi S,2018

2. Epidemiology of Renal Cell Carcinoma;Capitanio U;Eur Urol,2019

3. Influence of gene expression on survival of clear cell renal cell carcinoma;Berglund A;Cancer Med,2020

4. Chevrier, S., et al., An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell, 2017. 169(4): p. 736–749.e18.

5. Current and emerging therapies for first line treatment of metastatic clear cell renal cell carcinoma;Serzan MT;J Cancer Metastasis Treat,2021

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3